Abstract

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6

Page(s): 493

Download in electronic PDF format for $75
  • Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Page 1

Abstract

A formulation for preparing Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • ursodiol
  • formulation
  • ursodeoxycholic acid
  • secondary biliary acid
  • gallstones
  • primary biliary cholangitis
  • primary biliary cirrhosis
  • cholelithiasis

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • GASTROENTEROLOGY
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2019
Pg. 493
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 510-512
Stability of Ursodiol in SyrSpend SF Cherry Flavored
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
May/Jun 2020
Pg. 232
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 427
Ursodiol 50-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 70-76
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Jan/Feb 2018
Pg. 55
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2005
Pg. 480
Ursodiol 25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2015
Pg. 410
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 321
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 382
Ursodiol 150-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Nov/Dec 2004
Pg. 458-460
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
Author(s): McElhiney Linda F
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Jul/Aug 2021
Pg. 327
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 146
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Nov/Dec 2023
Pg. 493
Salicylic Acid 30% Gel
Author(s): Allen Loyd V Jr